On May 26, 2020, Sanofi announced that it had agreed to sell 11.8 million shares of Regeneron common stock through a registered offering at a price of $515.00 per share. Regeneron repurchased 9.8 million shares or $5 billion in common stock from Sanofi at the offering price less the underwriting discount.